Akzo Nobel N.V. AKZOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.92B | 3.01B | 2.79B | 2.76B | 2.98B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.92B | 3.01B | 2.79B | 2.76B | 2.98B |
| Cost of Revenue | 1.71B | 1.72B | 1.60B | 1.67B | 1.74B |
| Gross Profit | 1.21B | 1.29B | 1.19B | 1.09B | 1.23B |
| SG&A Expenses | 930.01M | 959.54M | 931.33M | 615.81M | 906.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 314.22M | 2.33M | -3.51M | -324.78M | 319.17M |
| Total Operating Expenses | 2.96B | 2.69B | 2.53B | 2.28B | 2.97B |
| Operating Income | -37.98M | 324.50M | 259.74M | 479.61M | 8.18M |
| Income Before Tax | -111.65M | 251.23M | 173.16M | 868.42M | -112.23M |
| Income Tax Expenses | 89.78M | 77.93M | 54.99M | 162.97M | 109.90M |
| Earnings from Continuing Operations | -201.43M | 173.30M | 118.17M | 705.44M | -222.13M |
| Earnings from Discontinued Operations | -1.15M | -1.16M | -- | 0.00 | -1.17M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.30M | -10.47M | -9.36M | -9.31M | -3.51M |
| Net Income | -204.88M | 161.67M | 108.81M | 696.13M | -226.81M |
| EBIT | -37.98M | 324.50M | 259.74M | 479.61M | 8.18M |
| EBITDA | 74.82M | 431.50M | 368.55M | 593.69M | 118.08M |
| EPS Basic | -1.20 | 0.94 | 0.64 | 4.07 | -1.33 |
| Normalized Basic EPS | -0.29 | 0.94 | 0.74 | 1.41 | -0.31 |
| EPS Diluted | -1.20 | 0.94 | 0.63 | 4.06 | -1.33 |
| Normalized Diluted EPS | -0.29 | 0.94 | 0.73 | 1.40 | -0.31 |
| Average Basic Shares Outstanding | 171.40M | 171.40M | 171.20M | 171.10M | 171.00M |
| Average Diluted Shares Outstanding | 171.40M | 171.60M | 172.22M | 171.84M | 171.00M |
| Dividend Per Share | -- | -- | -- | 1.79 | 0.00 |
| Payout Ratio | -5.06% | 193.53% | 3.23% | 6.19% | -13.92% |